Abstract
Our objective was to determine if β1-adrenergic receptor (β1-AR) and β2-AR gene polymorphisms influence heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) response to dobutamine during dobutamine stress echocardiography (DSE). Patients (n=163) undergoing clinically indicated DSE were enrolled. Dobutamine doses were titrated from 5 to 40 μg kg−1 min−1 at 3 min intervals and HR, SBP and DBP were measured. Genotypes were determined for β1-AR Ser49Gly, β1-AR Arg389Gly, β2-AR Arg16Gly and β2-AR Gln27Glu polymorphisms by polymerase chain reaction-restriction fragment length polymorphism analysis, pyrosequencing and single primer extension methods. β2-AR Glu27 homozygotes had a greater HR response at the highest dobutamine dose than Gln27 carriers (P=0.002). β2-AR Gly16 homozygotes had a lower HR response during 5–30 μg kg−1 min−1 of the dobutamine infusion protocol compared to Arg16 carriers (P=0.03). Differences in SBP by β2-AR codon 16 genotype and DBP by β1-AR codon 389 genotype were found at baseline and were maintained throughout DSE (P=0.06 and 0.02, respectively). However, the magnitude of SBP and DBP response to dobutamine did not differ significantly by β2-AR codon 16 or β1-AR codon 389 genotypes, respectively. These data suggest that the four selected β1- and β2-AR polymorphisms do not substantially influence the magnitude of hemodynamic response to dobutamine during DSE.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- DSE:
-
dobutamine stress echocardiography
- HR:
-
heart rate
- SBP:
-
systolic blood pressure
- DBP:
-
diastolic blood pressure
References
Mason DA, Moore JD, Green SA, Liggett SB . A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274: 12670–12674.
Rathz DA, Brown KM, Kramer LA, Liggett SB . Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002; 39: 155–160.
Green SA, Turki J, Innis M, Liggett SB . Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414–9419.
Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF . Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74: 44–52.
Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G et al. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 2003; 74: 372–379.
Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA et al. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003; 73: 366–371.
Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003; 9: 1300–1305.
Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF et al. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. Pharmacogenet Genomics 2005; 15: 227–234.
Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB . Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000; 139: 537–542.
Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B et al. Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33: 1425–1430.
La Rosee K, Huntgeburth M, Rosenkranz S, Bohm M, Schnabel P . The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 2004; 14: 711–716.
Usher Jr BW, O’Brien TX . Recent advances in dobutamine stress echocardiography. Clin Cardiol 2000; 23: 560–570.
Rodgers GP, Ayanian JZ, Balady G, Beasley JW, Brown KA, Gervino EV et al. American college of cardiology/American heart association clinical competence statement on stress testing: a report of the American college of cardiology/American heart association/American college of physicians—American society of internal medicine task force on clinical competence. J Am Coll Cardiol 2000; 36: 1441–1453.
Daly AL, Linares OA, Smith MJ, Starling MR, Supiano MA . Dobutamine pharmacokinetics during dobutamine stress echocardiography. Am J Cardiol 1997; 79: 1381–1386.
Lee CY, Pellikka PA, Shub C, Sinak LJ, Seward JB . Hypertensive response during dobutamine stress echocardiography. Am J Cardiol 1997; 80: 970–971.
Aquilante CL, Humma LM, Yarandi HN, Andrisin TE, Lewis JF, Hamilton KK et al. Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography. Am J Cardiol 2004; 94: 535–538.
Dhond MR, Whitley TB, Singh S, Nguyen TT, Bommer WJ . Incidence and significance of profound hypotension during dobutamine stress echocardiography. Clin Cardiol 2000; 23: 47–50.
Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH et al. Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 1999; 9: 511–516.
Buscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S et al. In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001; 11: 199–205.
Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70: 935–942.
O’Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ . The gain-of-function variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 2000; 99: 233–238.
Terra SG, McGorray SP, Wu R, McNamara DM, Cavallari LH, Walker JR et al. Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes (Lond) 2005; 29: 746–754.
Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL et al. Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001; 88: 1034–1037.
Holloway JW, Dunbar PR, Riley GA, Sawyer GM, Fitzharris PF, Pearce N et al. Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000; 30: 1097–1103.
Acknowledgements
This study was supported in part by grants from the National Institutes of Health HL68834 (to JAJ) and an American Foundation for Pharmaceutical Education Clinical Pharmacy Post-Pharm.D. Fellowship in the Biomedical Research Sciences (to CLA and LHC). Complete genotype, heart rate and blood pressure data from this study are available at www.Pharmgkb.org.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presentation of material as an abstract: These data were presented in part as an abstract at the 2002 Annual Meeting of the American College of Clinical Pharmacy, Albuquerque, New Mexico. Pharmacotherapy 2002 22:240.
Duality of Interest
None declared.
Rights and permissions
About this article
Cite this article
Aquilante, C., Yarandi, H., Cavallari, L. et al. β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography. Pharmacogenomics J 8, 408–415 (2008). https://doi.org/10.1038/sj.tpj.6500490
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500490
Keywords
This article is cited by
-
Functional effects of β1-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration
Clinical Research in Cardiology (2011)
-
Effect of the ADRB1 1165C>G and 145A>G polymorphisms on hemodynamic response during dobutamine stress echocardiography
European Journal of Clinical Pharmacology (2011)